Published in J Spinal Cord Med on January 01, 2007
Function of microglia and macrophages in secondary damage after spinal cord injury. Neural Regen Res (2014) 0.94
P2Y2 receptor expression is altered in rats after spinal cord injury. Int J Dev Neurosci (2010) 0.80
Hindlimb muscle morphology and function in a new atrophy model combining spinal cord injury and cast immobilization. J Neurotrauma (2013) 0.78
Blockade of P2 nucleotide receptors after spinal cord injury reduced the gliotic response and spared tissue. J Mol Neurosci (2011) 0.77
Toxoplasma gondii is dependent on glutamine and alters migratory profile of infected host bone marrow derived immune cells through SNAT2 and CXCR4 pathways. PLoS One (2014) 0.77
Effect of glutamine enriched nutrition support on surgical patients with gastrointestinal tumor: a meta-analysis of randomized controlled trials. Chin Med J (Engl) (2015) 0.75
Clinical proteomics of enervated neurons. Clin Proteomics (2016) 0.75
Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods (1981) 4.41
Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem (1974) 3.09
Factors influencing body composition in persons with spinal cord injury: a cross-sectional study. J Appl Physiol (1985) (2003) 2.23
Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J (2004) 1.93
Carbohydrate and lipid metabolism in chronic spinal cord injury. J Spinal Cord Med (2001) 1.74
Influence of complete spinal cord injury on skeletal muscle within 6 mo of injury. J Appl Physiol (1985) (1999) 1.66
Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg (2004) 1.65
Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil (2002) 1.60
Exercise and immune function. Recent developments. Sports Med (1999) 1.58
Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ (2002) 1.52
The Stockholm spinal cord injury study: 1. Medical problems in a regional SCI population. Paraplegia (1995) 1.39
Cause of death for patients with spinal cord injuries. Arch Intern Med (1989) 1.32
The effect of residual neurological deficit on oral glucose tolerance in persons with chronic spinal cord injury. Spinal Cord (1999) 1.32
Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol Sci (2003) 1.29
Glutamine and glutamate as vital metabolites. Braz J Med Biol Res (2003) 1.26
Mechanisms of the inflammatory response. Best Pract Res Clin Anaesthesiol (2004) 1.23
Glutamine and the immune system. Amino Acids (1999) 1.21
Vascular remodeling after spinal cord injury. Med Sci Sports Exerc (2003) 1.15
Exercise responses and quadriplegia. Med Sci Sports Exerc (1993) 1.14
Phenotypic adaptations in human muscle fibers 6 and 24 wk after spinal cord injury. J Appl Physiol (1985) (2002) 1.14
Acute molecular responses of skeletal muscle to resistance exercise in able-bodied and spinal cord-injured subjects. J Appl Physiol (1985) (2003) 1.13
Hematogenous macrophages express CD8 and distribute to regions of lesion cavitation after spinal cord injury. Exp Neurol (2003) 1.10
Glutamine metabolism by lymphocytes, macrophages, and neutrophils: its importance in health and disease. J Nutr Biochem (1999) 1.05
Circuit training provides cardiorespiratory and strength benefits in persons with paraplegia. Med Sci Sports Exerc (2001) 1.04
Spinal cord injury, exercise and quality of life. Sports Med (1995) 1.02
Influence of neurological level on immune function following spinal cord injury: a review. J Spinal Cord Med (2000) 0.99
Effect of n-6 and n-3 fatty acids on the survival of vincristine sensitive and resistant human cervical carcinoma cells in vitro. Cancer Lett (1994) 0.98
Alteration of immune system function in tetraplegics. A pilot study. Am J Phys Med Rehabil (1995) 0.96
Insulin resistance and sympathetic function in high spinal cord injury. Spinal Cord (1999) 0.94
Improved glucose tolerance and insulin sensitivity after electrical stimulation-assisted cycling in people with spinal cord injury. Spinal Cord (2002) 0.92
Fatigue compensation during FES using surface EMG. J Electromyogr Kinesiol (2003) 0.92
Acute exercise effects on the immune system. Med Sci Sports Exerc (2000) 0.92
Fuel utilization by cells of the immune system. Proc Nutr Soc (1995) 0.91
Influence of complete spinal cord injury on skeletal muscle mechanics within the first 6 months of injury. Eur J Appl Physiol (2000) 0.88
Intracellular distribution of some enzymes of the glutamine utilisation pathway in rat lymphocytes. Biochem Biophys Res Commun (1986) 0.88
Na+,K+-ATPase concentration and fiber type distribution after spinal cord injury. Muscle Nerve (2004) 0.87
Cardiac autonomic responses to progressive head-up tilt in individuals with paraplegia. Clin Auton Res (2003) 0.87
Sympathetic sudomotor skin activity in human after complete spinal cord injury. Auton Neurosci (2002) 0.86
Glucose intolerance in spinal cord injury. Arch Phys Med Rehabil (1983) 0.86
Can glutamine modify the apparent immunodepression observed after prolonged, exhaustive exercise? Nutrition (2002) 0.82
Autonomic dysreflexia increases plasma adrenaline level in the chronic spinal cord-injured rat. Neurosci Lett (2000) 0.81
Inflammatory response after neurosurgery. Best Pract Res Clin Anaesthesiol (2004) 0.81
Positive and negative feedback mechanisms in the neural regulation of cardiovascular function in healthy and spinal cord-injured humans. Circulation (2001) 0.81
Metabolism of rat skeletal muscle after spinal cord transection. Muscle Nerve (2000) 0.80
Lifelong exposure to dietary fish oil alters macrophage responses in Walker 256 tumor-bearing rats. Cell Immunol (2005) 0.80
Fish oil alters T-lymphocyte proliferation and macrophage responses in Walker 256 tumor-bearing rats. Nutrition (2006) 0.79
Plasma glutamine concentration in spinal cord injured patients. Life Sci (2005) 0.77
Activation of adrenal preganglionic neurons during autonomic dysreflexia in the chronic spinal cord-injured rat. Auton Neurosci (2002) 0.76
Effects of Prebiotic and Synbiotic Supplementation on Inflammatory Markers and Anthropometric Indices After Roux-en-Y Gastric Bypass: A Randomized, Triple-blind, Placebo-controlled Pilot Study. J Clin Gastroenterol (2016) 1.39
Decreased tumor growth in Walker 256 tumor-bearing rats chronically supplemented with fish oil involves COX-2 and PGE2 reduction associated with apoptosis and increased peroxidation. Prostaglandins Leukot Essent Fatty Acids (2007) 0.91
Low fish oil intake improves insulin sensitivity, lipid profile and muscle metabolism on insulin resistant MSG-obese rats. Lipids Health Dis (2011) 0.85
Anaerobic exercise reduces tumor growth, cancer cachexia and increases macrophage and lymphocyte response in Walker 256 tumor-bearing rats. Eur J Appl Physiol (2008) 0.84
Fish oil supplementation improves neutrophil function during cancer chemotherapy. Lipids (2011) 0.84
Fish oil supplementation reduces cachexia and tumor growth while improving renal function in tumor-bearing rats. Lipids (2012) 0.82
Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats. J Nutr Biochem (2004) 0.81
Soy lecithin supplementation alters macrophage phagocytosis and lymphocyte response to concanavalin A: a study in alloxan-induced diabetic rats. Cell Biochem Funct (2008) 0.81
Fish oil supplementation for two generations increases insulin sensitivity in rats. J Nutr Biochem (2012) 0.81
Ratio of n6 to n-3 fatty acids in the diet affects tumor growth and cachexia in Walker 256 tumor-bearing rats. Nutr Cancer (2005) 0.81
Cancer cachexia and tumor growth reduction in Walker 256 tumor-bearing rats supplemented with N-3 polyunsaturated fatty acids for one generation. Nutr Cancer (2003) 0.80
Lifelong exposure to dietary fish oil alters macrophage responses in Walker 256 tumor-bearing rats. Cell Immunol (2005) 0.80
β-Hydroxy-β-methylbutyrate modifies human peripheral blood mononuclear cell proliferation and cytokine production in vitro. Nutrition (2010) 0.79
Fish oil alters T-lymphocyte proliferation and macrophage responses in Walker 256 tumor-bearing rats. Nutrition (2006) 0.79
Effect of fish oil supplementation for 2 generations on changes in macrophage function induced by Walker 256 cancer cachexia in rats. Int J Cancer (2007) 0.78
Effect of fish oil supplementation for two generations on changes of lymphocyte function induced by Walker 256 cancer cachexia in rats. Nutr Cancer (2009) 0.77
Glucose intolerance induced by glucocorticoid excess is further impaired by co-administration with β-hydroxy-β-methylbutyrate in rats. Appl Physiol Nutr Metab (2013) 0.77
Glucose metabolism by lymphocytes, macrophages, and tumor cells from Walker 256 tumor-bearing rats supplemented with fish oil for one generation. Cell Biochem Funct (2008) 0.77
α-Linolenic Fatty Acid Supplementation Decreases Tumor Growth and Cachexia Parameters in Walker 256 Tumor-Bearing Rats. Nutr Cancer (2015) 0.76
Disruption of glucose tolerance caused by glucocorticoid excess in rats is partially prevented, but not attenuated, by arjunolic acid. Indian J Exp Biol (2014) 0.76
The effects of peroxovanadate and peroxovanadyl on glucose metabolism in vivo and identification of signal transduction proteins involved in the mechanism of action in isolated soleus muscle. Mol Cell Biochem (2005) 0.76
Dietary supplementation with soybean lecithin increases pulmonary PAF bioactivity in asthmatic rats. J Nutr Biochem (2009) 0.76
Lymphocytes transfer [(14)C]-labeled fatty acids to skeletal muscle in culture; modulation by exercise. Cell Biochem Funct (2010) 0.75